Skip to content

Personalized intervention for late-life depression: a multicenter clinical randomized controlled trial

Personalized intervention for late-life depression: a multicenter clinical randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087737
Enrollment
Unknown
Registered
2024-08-02
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late-life depression

Interventions

Percision therapy group:Identify subtypes by Semi-supervised learning, select individualized precision treatment plans based on these subtypes.
Conventional treatment group:Standard medication treatment plans based on clinical experience.

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age = 60 years, regardless of gender; 2.Meeting the diagnostic criteria for Major Depressive Disorder according to DSM-5; 3.HAMD-17 score = 17; 4.Treatment-naive patients at first episode, or patients whose medication regimen has been stable for 4 weeks prior to enrollment, or patients who have relapsed and have not received antidepressant treatment for more than 6 months; 5.Agree to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Meeting the diagnostic criteria for other mental disorders as per DSM-5, such as bipolar disorder or schizophrenia; 2.High risk of suicide: HAMD-17 scale suicide item scores of 3 or 4, or assessed by the investigator as having a high risk of suicide; 3.Hypothyroidism or severe physical illnesses of the heart, liver, kidneys, etc., that contraindicate participation in the study; 4.Neurological conditions such as central nervous system infections, stroke, hydrocephalus, brain tumors, or epilepsy; 5.Currently participating in other clinical trials; 6.Contraindications for MRI examinations: presence of a pacemaker, history of brain surgery with retained aneurysm clips, etc.; 7.Any other condition assessed by the investigator as unsuitable for participation in the trial.

Design outcomes

Primary

MeasureTime frame
Clinical remission rate;

Secondary

MeasureTime frame
Remission time;Response rate;Clinical Global Impression-Improvement;Clinical Global Impression-Severity;Hamilton Depression Scale;Hamilton Anxiety Scale;Cognitive test scores;

Countries

China

Contacts

Public ContactNing Yuping

The Affiliated Brain Hospital of Guangzhou Medical University

ningjeny@126.com+86 20 8126 8181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026